Search Results - "Elsen, Peter J. van den"

Refine Results
  1. 1

    Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance by Vijayan, Saptha, Sidiq, Tabasum, Yousuf, Suhail, van den Elsen, Peter J., Kobayashi, Koichi S.

    Published in Immunogenetics (New York) (01-03-2019)
    “…Major histocompatibility complex (MHC) class I and class II molecules play critical roles in the activation of the adaptive immune system by presenting…”
    Get full text
    Journal Article
  2. 2

    Expression regulation of major histocompatibility complex class I and class II encoding genes by van den Elsen, Peter J

    Published in Frontiers in immunology (01-01-2011)
    “…Major histocompatibility complex (MHC)-I and MHC-II molecules play an essential role in the immune response to pathogens by virtue of their ability to present…”
    Get full text
    Journal Article
  3. 3

    Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies by van Noort, Johannes M, van den Elsen, Peter J, van Horssen, Jack, Geurts, Jeroen J G, van der Valk, Paul, Amor, Sandra

    Published in CNS & neurological disorders drug targets (01-02-2011)
    “…For the development of novel central nervous system (CNS) drugs to promote neuroprotection, it is helpful to gain a betterunderstanding of natural…”
    Get more information
    Journal Article
  4. 4

    Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes by van Essen, T Huibertus, van Pelt, Sake I, Bronkhorst, Inge H G, Versluis, Mieke, Némati, Fariba, Laurent, Cécile, Luyten, Gregorius P M, van Hall, Thorbald, van den Elsen, Peter J, van der Velden, Pieter A, Decaudin, Didier, Jager, Martine J

    Published in PloS one (20-10-2016)
    “…Uveal melanoma (UM) with an inflammatory phenotype, characterized by infiltrating leukocytes and increased human leukocyte antigen (HLA) expression, carry an…”
    Get full text
    Journal Article
  5. 5
  6. 6

    NLRC5: a key regulator of MHC class I-dependent immune responses by Kobayashi, Koichi S., van den Elsen, Peter J.

    Published in Nature reviews. Immunology (01-12-2012)
    “…The identification of NLRC5 as a transcriptional transactivator of MHC class I genes has shed light on the regulation of MHC class I expression. This Progress…”
    Get full text
    Journal Article
  7. 7

    NLR family member NLRC5 is a transcriptional regulator of MHC class I genes by Meissner, Torsten B., Li, Amy, Biswas, Amlan, Lee, Kyoung-Hee, Liu, Yuen-Joyce, Bayir, Erkan, Iliopoulos, Dimitrios, van den Elsen, Peter J., Kobayashi, Koichi S., Strominger, Jack

    “…MHC class I plays a critical role in the immune defense against viruses and tumors by presenting antigens to CD8 T cells. An NLR protein, class II…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Chemical and genetic control of IFNγ‐induced MHCII expression by Wijdeven, Ruud H, van Luijn, Marvin M, Wierenga‐Wolf, Annet F, Akkermans, Jimmy J, van den Elsen, Peter J, Hintzen, Rogier Q, Neefjes, Jacques

    Published in EMBO reports (01-09-2018)
    “…The cytokine interferon‐γ (IFNγ) can induce expression of MHC class II (MHCII) on many different cell types, leading to antigen presentation to CD4 + T cells…”
    Get full text
    Journal Article
  10. 10

    Epigenetics in atherosclerosis and inflammation by Wierda, Rutger J., Geutskens, Sacha B., Jukema, J. Wouter, Quax, Paul H.A., van den Elsen, Peter J.

    Published in Journal of cellular and molecular medicine (01-06-2010)
    “…•  Introduction •  Epigenetics explained ‐  Epigenetic alterations are reversible •  Atherosclerosis •  Epigenetics and association with atherosclerosis • …”
    Get full text
    Journal Article
  11. 11

    Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease by Pons, Douwe, de Vries, Florentine R., van den Elsen, Peter J., Heijmans, Bastiaan T., Quax, Paul H.A., Jukema, J. Wouter

    Published in European heart journal (01-02-2009)
    “…Significant progress has been made in the clinical management of a variety of cardiovascular diseases. Nevertheless, the therapeutic efficacy of the current…”
    Get full text
    Journal Article
  12. 12
  13. 13

    The epigenetic factor PCAF regulates vascular inflammation and is essential for intimal hyperplasia development by de Jong, Rob C M, Ewing, Mark M, de Vries, Margreet R, Karper, Jacco C, Bastiaansen, Antonius J N M, Peters, Hendrika A B, Baghana, Fabiana, van den Elsen, Peter J, Gongora, Céline, Jukema, J Wouter, Quax, Paul H A

    Published in PloS one (10-10-2017)
    “…Genetic P300/CBP-associated factor (PCAF) variation affects restenosis-risk in patients. PCAF has lysine acetyltransferase activity and promotes nuclear factor…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Antigen-independent acquisition of MHC class II molecules by human T lymphocytes by Undale, Anita H., van den Elsen, Peter J., Celis, Esteban

    Published in International immunology (01-10-2004)
    “…We report here that human T lymphocytes have the capacity of acquiring large amounts of MHC class II molecules from various types of antigen-presenting cells…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Simvastatin reduces CCL2 expression in monocyte-derived cells by induction of a repressive CCL2 chromatin state by Zanette, Dalila L, van Eggermond, Marja C.J.A, Haasnoot, Geert, van den Elsen, Peter J

    Published in Human immunology (01-01-2014)
    “…Abstract Statins exert anti-inflammatory characteristics, besides their lipid lowering properties, and may display beneficial effects for the treatment of…”
    Get full text
    Journal Article
  19. 19

    E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII) by van der Stoep, Nienke, Quinten, Edwin, Rezende, Marisa Marcondes, van den Elsen, Peter J.

    Published in Blood (01-11-2004)
    “…In B cells, expression of CIITA and resulting major histocompatibility complex II (MHCII) is mediated exclusively by promoter III (CIITA-PIII) activation…”
    Get full text
    Journal Article
  20. 20

    Genetic and Epigenetic Regulation of CCR5 Transcription by Wierda, Rutger J, van den Elsen, Peter J

    Published in Biology (13-12-2012)
    “…The chemokine receptor CCR5 regulates trafficking of immune cells of the lymphoid and the myeloid lineage (such as monocytes, macrophages and immature…”
    Get full text
    Journal Article Book Review